The World Health Organisation (WHO) reports that diabetes affects roughly 180 million people worldwide and that cardiovascular illnesses account for nearly 30% of all fatalities worldwide. Applications involving radio frequency (RF) or microwave technology are crucial to medical diagnosis and illness prevention. The most recent developments in the field of implantable medical devices (IMDs), such as biomedical telemetry, allow biosignals to be monitored remotely via wireless communication technology. Providing correct information to the external monitoring station is the primary function of the health maintenance monitoring scheme. Because wireless communication lessens the invasiveness of electromagnetic (EM) medical equipment, it is extremely helpful in improving patient comfort during treatment. The first swallowable pills with sensing capabilities and the introduction of pacemakers in the early 1960s both demonstrated the significance of implantable medical devices (IMDs), which enable disease monitoring and therapy. Using IMDs with wireless connection has allowed for the monitoring of both system performance and patient status. IMDs have been widely employed in healthcare systems to gather real-time signals from biosensors or preprocessed physiological bio-signals for early disease identification, improving treatment quality and promoting healthy living.
Read full abstract